Yu Wen Edith Chang
About Yu Wen Edith Chang
Yu Wen Edith Chang is the Director of Development Operations, Product and Analytical Development, Cell Therapy Development at Bristol Myers Squibb and a Senior Manager at US Pharmacopeia.
Title
Yu Wen Edith Chang holds the position of Director Of Development Operations, Product and Analytical Development, Cell Therapy Development at Bristol Myers Squibb.
Current Roles
Yu Wen Edith Chang is currently serving as the Director Of Development Operations, Product and Analytical Development, Cell Therapy Development at Bristol Myers Squibb. In addition, she holds the role of Senior Manager at US Pharmacopeia, where she was formerly a Principal Scientist - Team Leader.
Education and Expertise
Yu Wen Edith Chang completed a Ph.D. in Biochemistry at the University of California, Riverside. Her academic background has equipped her with a deep understanding of biochemistry, which she applies to her current work in cell therapy development and analytical development.
Professional Background
Yu Wen Edith Chang has an extensive professional background at US Pharmacopeia. She served as a Scientific Liaison from 2014 to 2018, Reference Standards Scientist IV, Biologics from 2011 to 2014, and Scientist III from 2010 to 2011. She has been associated with various roles at US Pharmacopeia over the years, contributing to scientific liaison and reference standards for biologics.
Responsibilities at Bristol Myers Squibb
At Bristol Myers Squibb, Yu Wen Edith Chang leads the Development Operations department. Her responsibilities include managing Flow Cytometry instrumentation and resources, supporting lab operations, collaborating with process and analytical development teams to implement new technologies, and supporting critical reagent management and cellular material supply.